LOIZZI, VERA
 Distribuzione geografica
Continente #
NA - Nord America 9.340
EU - Europa 2.347
AS - Asia 768
OC - Oceania 11
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
Totale 12.481
Nazione #
US - Stati Uniti d'America 9.331
CN - Cina 673
SE - Svezia 615
UA - Ucraina 442
IT - Italia 395
DE - Germania 299
FI - Finlandia 228
FR - Francia 143
GB - Regno Unito 129
IE - Irlanda 36
BE - Belgio 31
IN - India 29
VN - Vietnam 22
IR - Iran 13
CA - Canada 9
AU - Australia 8
JP - Giappone 8
NL - Olanda 7
RU - Federazione Russa 7
KR - Corea 6
EU - Europa 5
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
TR - Turchia 3
AM - Armenia 2
AR - Argentina 2
CL - Cile 2
ES - Italia 2
HU - Ungheria 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
ZA - Sudafrica 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
HK - Hong Kong 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
PK - Pakistan 1
PL - Polonia 1
SG - Singapore 1
SI - Slovenia 1
Totale 12.481
Città #
Fairfield 1.087
Chandler 1.034
Jacksonville 959
Woodbridge 699
Ashburn 625
Houston 563
Cambridge 492
Nyköping 478
Seattle 465
Ann Arbor 410
Wilmington 385
Lawrence 243
Roxbury 235
Nanjing 197
New York 154
Des Moines 149
Beijing 130
Bari 129
Princeton 119
Boardman 117
Dearborn 68
Inglewood 66
Hebei 60
San Diego 57
Shenyang 57
Nanchang 48
Jiaxing 39
Dublin 36
Tianjin 35
Brooklyn 31
Brussels 31
Washington 28
Paris 27
Matera 26
Changsha 22
Dong Ket 21
Helsinki 20
London 19
Milan 19
Pune 18
Falls Church 15
Los Angeles 15
Redwood City 15
Hefei 13
Marseille 12
Kunming 11
Lissone 11
Auburn Hills 10
San Francisco 10
Fasano 8
Norwalk 8
Zhengzhou 8
Chiswick 7
Toronto 7
Ardabil 6
Guangzhou 6
Indiana 6
Jinan 6
San Mateo 6
Taranto 6
Chongqing 5
Cosenza 5
Edinburgh 5
Ostuni 5
Savigliano 5
St Louis 5
Tokyo 5
Acton 4
Augusta 4
Barletta 4
Canberra 4
Fuzhou 4
Kilburn 4
Leawood 4
Palermo 4
Redmond 4
Simi Valley 4
Southwark 4
Baotou 3
Hangzhou 3
Hanover 3
Hounslow 3
Melbourne 3
Ningbo 3
Rome 3
San Jose 3
Tappahannock 3
Udine 3
Alessandria 2
Amsterdam 2
Arzano 2
Bergamo 2
Bratislava 2
Buenos Aires 2
Cerignola 2
Chengdu 2
Chicago 2
Grafing 2
Grottaglie 2
Haikou 2
Totale 9.717
Nome #
The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication 142
A case of sarcoidosis mimicking recurrences of endometrial cancer. 133
Cystoid macular edema secondary to paclitaxel therapy for ovarian cancer: A case report 132
Rapid growth of myxoid leiomyosarcoma of the vulva during pregnancy: a case report 114
Goblet-cell carcinoid of the ovary: A case report with ultrastructural analysis 114
Chronic Endometritis, a Common Disease Hidden Behind Endometrial Polyps in Premenopausal Women: First Evidence From a Case-Control Study. 110
A phase II study: dose-dense carboplatin and paclitaxel as neoadjuvant chemotherapy in locally advanced cervical cancer 110
A rare case of choroidal metastasis presented after conservative management of endometrial cancer 105
Human ovarian cancer tissue exhibits increase of mitochondrial biogenesis and cristae remodeling 99
Prognostic Factors and Outcomes in 28 Cases of Uterine Leiomyosarcoma 97
Pseudo-Meigs syndrome and elevated Ca125 associated with struma ovarii 95
Experience With First Level Ultrasound And Echocardiography For A Selected And An Unselected Population. 94
An unusual presentation of struma ovarii mimicking a malignant process 93
Carcinosarcoma of the vulva: a case report 93
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24) 93
NEOADJUVANT CHEMOTHERAPY (NACHT) FOR LOCALLY ADVANCED CERVICAL CANCER (LACC): OUR EXPERIENCE WITH TIP (TAXOL+IFOSFAMIDE+PLATINUM) REGIMEN 92
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 91
Malignant Mixed Müllerian Tumour of the Uterus: Analysis of 44 Cases 90
Tumor Size, Histology and Smoking Are Prognostic in the Treatment of Small-Cell Cervical Carcinoma 87
Hysteroscopic evaluation of menopausal patients with sonographically atrophic endometrium. 87
Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium. 86
Borderline epithelial tumors of the ovary: experience of 55 patients 84
A case of Sertoli-Leydig cell tumor in a postmenopausal woman 84
Locally-advanced cervical cancer associated with complete uterine prolapse 83
BONE METASTASES AS PRESENTING SIGN OF MAMMARY-LIKE VULVAR ADENOCARCINOMA 83
Mitochondrial Dysfunctions in Type I Endometrial Carcinoma: Exploring Their Role in Oncogenesis and Tumor Progression 83
null 83
GROIN RECURRENCE IN CARCINOMA OF THE VULVA: MANAGEMENT AND OUTCOME 82
Adjuvant chemotherapy does not improve disease-free survival in FIGO stage IC ovarian granulosa cell tumors: The MITO-9 study 81
US and MR Findings in Primary Vaginal Leiomyoma: A Case Report. 80
The PGC-1a-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer. 79
Unsuspected diagnosis of uterine leiomyosarcoma after laparoscopic myomectomy 79
A case of sarcoidosis mimicking recurrences of endometrial cancer. 79
Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer 78
Small cell carcinoma of the uterine cervix metastasising to the cerebellum 78
Antimicrobial prophylaxis in vaginal gynecologic surgery: a prospective randomized study comparing amoxicillin-clavulanic acid with cefazolin 77
Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer 77
Chemotherapy in Recurrent Vulvar Carcinoma: A Phase II Study Using Combination of Cisplatin and Vinorelbine 76
Oral altretamine used as salvage therapy in recurrent ovarian cancer 76
Choice of cesarean section and perception of legal pressure 75
Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: What prognostic factors are important? 75
Ultrasound presurgical staging in endometrial cancer. 75
Unsuspected diagnosis of uterine leiomyosarcoma after laparoscopic myomectomy. 74
null 74
Non-puerperal uterine inversion due to uterine sarcoma 73
null 73
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary - A multivariate analysis 72
Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer 71
Leptomeningeal involvement after remission of brain metastases from ovarian cancer. 71
Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium 70
null 70
Bowel Dysfunction following Nerve-Sparing Radical Hysterectomy for Cervical Cancer: A Prospective Study. 69
Pregnancy related cancer in Apulia. A population based linkage study. 69
Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 69
Borderline epithelial tumors of the ovary 68
null 68
Lymphadenectomy versus no lymphadenectomy in endometrial carcinoma: a retrospective analysis of 410 patients. 68
Mimic of vulvar cancer: primary vaginal squamous carcinoma on cystocele 67
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 67
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: A retrospective, multicenter study 66
null 66
Unsuspected Diagnosis of Uterine Leiomyosarcoma after Laparoscopic Myomectomy 66
Lymphadenectomy versus no lymphadenectomy in endometrial carcinoma: A retrospective analysis of 410 patients 66
Chemoradiation: A new approach for the treatment of cervical cancer 66
Central nervous system metastases from epithelial ovarian cancer: prognostic factors and outcomes. 66
Resectoscopic Metroplasty with Uterine Septum Excision: A Histologic Analysis of the Uterine Septum 66
null 65
null 64
The diagnostic role of "in utero" magnetic resonance imaging 64
null 64
null 63
Hysteroscopic Evaluation Of Menopausal Women With Endometrial Thickness Of 4 Mm Or More. 63
BRCA1/2 MUTATIONS AND ‘’FOUNDER EFFECT’’ : THE CASE OF APULIA 63
Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy 63
null 63
Paget disease of the vulva an analysis of 24 cases 62
null 61
Benign metastasizing leiomyoma in the lung: a case report 61
The importance of vascular immune regulation in the prognosis of women with advanced ovarian cancer 61
A Longitudinal Study Of The Cervix Length In The Third Trimester Of Pregnancy By Transvaginal Ultrasound. 60
null 59
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 59
MALIGNANT MIXED MÜLLERIAN TUMOUR (MMMT) OF THE UTERUS: ANALYSIS OF 44 CASES 58
DOSE-DENSE WEEKLY CARBOPLATIN AND PACLITAXEL AS NEOADJUVANT CHEMOTERAPY IN LOCALLY ADVANCED CERVICAL CANCER 58
null 57
Aggressive angiomyxoma of the pelvis. A case report. 56
A longitudinal study of the cervix in the third trimester of pregnancy by transvaginal ultrasound 56
Neoadjuvant chemotherapy for stage III and IV epithelial ovarian cancer: A comparative study 55
Platinum-based neoadjuvant chemotherapy in locally advanced cervical carcinoma. 54
Asfissia perinatale e problemi medico-legali 54
Beyond BRCA1/2: Homologous Recombination Repair Genetic Profile in a Large Cohort of Apulian Ovarian Cancers 54
Increased serum beta-HCG levels for 5 years before clinical diagnosis of ovarian dysgerminoma 53
null 53
Neoadjuvant chemotherapy for stage III and IV epithelial ovarian cancer: a comparative study. 53
“Medicina Difensiva” Nella Scelta Del Taglio Cesareo. ” 52
Acute Urinary Retention Due To Uterine Myoma: A Clinical Case. Arch Ital Urol Androl 52
A case of acute lymphoblastic leukaemia mimicking an ovarian malignant tumor 52
[Clinical experience with uterine sarcoma]. FT Esperienza clinica sui sarcomi uterini 52
null 52
Transvaginal color-Doppler ultrasound in evaluation of endometrial carcinoma 51
Totale 7.446
Categoria #
all - tutte 52.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019660 0 0 0 0 0 0 0 0 0 0 348 312
2019/20203.115 600 211 82 220 318 215 355 216 358 162 303 75
2020/20212.145 215 109 194 114 218 187 241 121 216 278 141 111
2021/20221.620 77 188 16 110 51 115 30 115 78 104 265 471
2022/20232.804 393 228 168 261 366 359 26 324 491 21 91 76
2023/2024993 73 213 69 101 124 286 34 57 9 25 2 0
Totale 12.850